TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: attainment of uterine quiescence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Speech Recognition in Quiet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return rate of completed FIT
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Intramuscular fat infiltration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thymus and activation regulated chemokine (TARC) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Spleen size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean % Change in Body Mass Index (BMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Subjects With Small Bowel Bacterial Overgrowth (SBBO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Spouse Self Report of Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Spouse Self Report of Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Average Mean Arterial Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Breadth of T-cell responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Overall adenoma detection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Activity/Exercise in Patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Activity/Exercise in Partners
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eating Behavior (% Saturated Fat) in Patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Eating Behavior (% Saturated Fat) in Partners
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Spastic Paraplegia Rating Scale (SPRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite morbidity endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The incidence and severity of AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Self-efficacy in the use of male condom
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safe sexual behavior
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Number of participants undergoing lumbar spine surgery with complete follow-up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: change in patient understanding of anemia and treatment options
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: POGO score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Absolute Brain Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Insertion Procedure-related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Measurement of IL-4, 5, 6, 8, 16, MIG, TNF-alpha, MCP-1 in EBC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Measurement of ECP, eosinophil blood count, cotinine and total IgE in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Device-oriented clinical end points (DoCE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Glomerular Filtration Rate by Iohexol Clearance at Week 52
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Cumulative Incidence of Graft Loss, Toxicities ≥ Grade 3 Per the DAIDS Toxicity Table and/or Permanent Treatment Discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Completion of Colorectal Cancer Screening Tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of myocardial metabolic rate of glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of patients with treatment changes after CT
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Days with symptoms
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change in Activity Levels
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of participants with acute response to sugar water vs. pom juice vs. water
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with hormonal changes in response to sugar water vs. pom juice vs. water
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of participants with acute response of plasma nitric oxide (NO) from sugar water vs. pom juice vs. water
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Ventricular Tachycardia or Ventricular Fibrillation (VT/VF) triggered ICD interventions or sudden death
Endpoint domain: Mortality/survival
Primary endpoint: Microbiota-dependent TMAO-response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum concentration of biogenic amine metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in on-treatment platelet reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence, nature and severity of Adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Best Response of Complete Remission or Partial Remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to effective airway insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change From Baseline in the Composite Score of BME, Synovitis, and Tenosynovitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Peak Inspiratory Capacity (IC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: TFV concentrations in plasma and genital tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TFV-DP concentrations in genital tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of active lesions developed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Emergency Department Length of stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Proportion of subjects treated continuously with triptorelin
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Skin response to sun exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: change of pDCs/NK/CD4+ T/Treg cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: change of IFN-α2/IFN-γ/TGF-β1/IL-2/IL-6/IL-10/IL-17A/TNF-α1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Extent of test-specific distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Absolute coronary resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Microvascular obstruction on MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PINP Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of force development (RFD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of infants sharing bacterial strains
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percent Change in Hippocampus Connectivity Index (HCI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endothelial-dependent dilation of the brachial artery (FMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: post-bronchodilator FEV1 change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: post-bronchodilator change in FVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 5 year cardiovascular outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean anaerobic threshold improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pAKT Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline plasma cortisol level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change from baseline plasma ACTH level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change from baseline 24-hour urine free cortisol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Irritable bowel syndrome symptom severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Amino acid levels in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of hepatitis
Endpoint domain: Adverse events/effects
Primary endpoint: Alcohol use (days of use and days of heavy drinking)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the proportion of patients achieving glycaemic control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in the proportion of patients achieving BP control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean change in balance score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of influenza virus infections
Endpoint domain: Adverse events/effects
Primary endpoint: End Treatment Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical parameters (adverse events, vital signs, ECG)
Endpoint domain: Adverse events/effects
Primary endpoint: Laboratory parameters (chemistry, hematology)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expression of VDR, PPARγ and PGC1α gene
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation between βig-h3 expression and TNM/UICC staging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rate of decline in viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of Participants With at Least One Symptomatic Hypoglycemic Event
Endpoint domain: Adverse events/effects
Primary endpoint: Vertical Transmission Rate
Endpoint domain: Mortality/survival
Primary endpoint: Mitral regurgitation grade by ASE criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change in grade III and IV toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: change in immunogenicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Composite of Pharmacokinetics (Cmax, AUClast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Myocardial injury after non-cardiac surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Endoscopic Improvement Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change From Baseline Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Oxygen Desaturation Index (ODI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Objective snoring pre and post therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Calcemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Subjective parathyroid fluorescence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective parathyroid fluorescence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kyphosis degree
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insomnia Severity Index (ISI) Short-term
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Insomnia Severity Index (ISI) Long-term
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Pharmacokinetics of Montelukast
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preliminary safety of Montelukast
Endpoint domain: Adverse events/effects
Primary endpoint: Performance of the Lateral Flow Device Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of patients with newly identified HIV infection
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of patients with idiopathic cytopenia with a mutation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Atelectasis volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Functional ability to perform activities of daily living
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in acute post-operative pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of analgesic drugs consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Visual Analogue Scale of the EuroQol-5D
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Complete Response Unconfirmed (CRu)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postpartum smoking resumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systemic drug clearance (CL/F)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRI variations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: marginal integrity of restorations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Streptococcus Pneumoniae in Nasopharynx
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Density of Streptococcus Pneumoniae in the Nasopharynx
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Spermatic aneuploidy rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Maximum tolerated dose of erlotinib hydrochloride
Endpoint domain: Adverse events/effects
Endpoint subdomain: Any subdomain
Primary endpoint: Spasticity in the lower extremities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily spasm frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ease of Communication
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change From Baseline in C-terminal Propeptide of Procollagen Type I (PICP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of total radioactivity excreted in urine and feces combined (µg) from baseline at Day 10
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EEG frequency ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Latency of P300-component
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Apoptotic cell death
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drug disposition of fluconazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pharmacokinetics outcomes
Primary endpoint: Self-reported arousal
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-reported valence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Perceived relaxation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Adverse Experiences
Endpoint domain: Adverse events/effects
Primary endpoint: Food-specific Immunoglobulin G4 antibody reactions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Stimulation of Growth After 12 Months (Delta Z-score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Timing of first post operative bowel movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Prevalence of adenomas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: days of stay at hospital after treatment and discharge
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: serum zinc before and after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Diabetic cardiovascular autonomic function evaluated by short-term heart rate variability test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diabetic cardiovascular autonomic function evaluated by Ewing's test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement of signs and symptoms associated with constipation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Ocular Perfusion Pressure (OPA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of recent infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Patient-reported Pain at Passage of Insertion Device Through Cervix
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Responder ratio of GOS (Global Overall Symptom)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute Wound Size Reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in frequency of CD49d+ neutrophils in nasal lavage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in NT-proBNP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Successful Neutrophil Recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of Subjects With Antibiotic Related Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative opioid measured in Milligram Morphine Equivalent (MME)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative Pain Scores measured with standard pain scores (0-10)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Competence Score From the Psychosocial Impact of Assistive Devices Scale (PIADS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Stroop Color and Word Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of subjects with Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline In Sexual Function On The Pregnant Women's FSFI Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change From Baseline In Sexual Function On The Men With a Pregnant Wife On The ASEX Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change From Baseline In Sexual Satisfaction On The Pregnant Women's New Sexual Satisfaction Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change From Baseline In Sexual Satisfaction On The Men With a Pregnant Wife The New Sexual Satisfaction Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Primary free survival
Endpoint domain: Mortality/survival
Primary endpoint: number and type of clinical cases with consensus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stroke, transient ischemic attack (TIA) and systemic embolism events
Endpoint domain: Mortality/survival
Primary endpoint: Bleeding (Frequency, Location, Severity, Type of intervention and Outcome)
Endpoint domain: Adverse events/effects
Primary endpoint: Death (CV and non-CV)
Endpoint domain: Mortality/survival
Primary endpoint: Constant-Murley Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in the Timed Up-and-Go test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Experiencing ≥1 Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Discontinuing from Study Treatment due to an Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment response in IgG4-RD patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physician Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Yale-Brown Obsessive-Compulsive Scale (YBOCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety as Measured by the Number of Participants Experiencing Adverse Events
Endpoint domain: Adverse events/effects